Patent Covering Endograft Device Is Obvious, Petitioner Tells Patent Board
ALEXANDRIA, Va. — In a Sept. 28 petition for inter partes review filed with the Patent Trial and Appeal Board, a medical technology company asserts that a patented endograft device is...To view the full article, register now.
Already a subscriber? Click here to view full article